HSCI Community News
Upcoming Events
ISSCR 12th Annual Meeting
Vancouver Convention Center
June 18 - 21

CCRM: The Business of Regenerative Medicine
Toronto, Ontario
July 14 -16
Funding and Awards
All three HSCI faculty to present at Brigham & Women's 'shark tank' are named winners. Congrats to Ben Humphreys, MD, PhD; Jeff Karp, PhD; and Tracy Young-Pearse, PhD.

Richard Lee, MD, is finalist in   Star Family Challenge for Promising Scientific Research
New Members
HSCI welcomes Principal Faculty member, Ya-Chieh Hsu, PhD, who recently joined HSCRB; and Affiliated Faculty members Martin Yarmush, MD, PhD, of HST and MGH's Basak Uygun, PhD.
Job Postings
Media Mentions
The next wave of cancer cures could come from nasty viruses

Study supports durability of Parkinson's treatment
Contact Us
Have anything you'd like to share? Contact joseph_caputo@harvard.edu.
A new model of liver regeneration
Fernando Camargo, PhD, and team find Hippo inactivation causes mature liver cells to revert back to stem cell-like state.
Fernando Camargo finds mature liver cells dedifferentiate.

Harvard scientists at Boston Children's Hospital have new evidence in mice that it may be possible to repair a chronically diseased liver by forcing mature liver cells to revert back to a stem cell-like state. The results were published in Cell. Read the full story.
A vaccine for heart attack?
Kiran Musunuru, MD, PhD, and Penn collaborators use gene therapy shot to control cholesterol in mice.
Kiran Musunuru, MD, PhD

Harvard and Brigham & Women's scientists have developed a "genome editing" approach for permanently reducing cholesterol levels in mice with a single injection, potentially reducing heart attack risk by up to 90 percent. Their work was published in Circulation Research. Read on.
Literature Highlights